Eleni Perrakis

Eleni Perrakis is a member of a large international collaboration between dozens of worldwide cancer research institutes. Their goal is the understanding of breast cancer genetics.

They managed to understand how two gene variations, rs10816625 and rs13294895, are both parts of the chromosome 9. The first variation increases 12% the chance for a woman to have breast cancer and the second variation increases the chance of developing breast cancer by 9% compared to women who does not have those genes in their DNA.

She started her education at National and Kapodistrian University of Athens in 2006 and she got her BSc in Biology in 2011. Then she went to the University of Glasgow where she got her Master of Science in 2012 with a distinction.

In 2012 she was a research assistant in the University of Edinburgh for seven months. In October 2013 she joined the Institute of Cancer Research in Chelsea, London. There she started her research for breast cancer.

She won the Silver Poster Award for the Poster title: “The role of rs9282641 polymorphism of the CD86 gene in susceptibility to multiple sclerosis. A PhD proposal.”